Cap-dependent endonuclease-IN-1 structure
|
Common Name | Cap-dependent endonuclease-IN-1 | ||
|---|---|---|---|---|
| CAS Number | 2365473-17-0 | Molecular Weight | 540.54 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C27H22F2N2O6S | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of Cap-dependent endonuclease-IN-1Cap-dependent endonuclease-IN-1 is an orally active cap-dependent endonuclease inhibitor with high potency. Cap-dependent endonuclease-IN-1 can be used for the research of influenza[1][2]. |
| Name | Cap-dependent endonuclease-IN-1 |
|---|
| Description | Cap-dependent endonuclease-IN-1 is an orally active cap-dependent endonuclease inhibitor with high potency. Cap-dependent endonuclease-IN-1 can be used for the research of influenza[1][2]. |
|---|---|
| Related Catalog | |
| References |
[1]. Ming-Chu Hsu, et al. Cap-dependent endonuclease inhibitors. Patent WO2019144089A1. [2]. Chi-Feng Yen, et al. Amorphous solid dispersion formulation. Patent US20220202817A1. |
| Molecular Formula | C27H22F2N2O6S |
|---|---|
| Molecular Weight | 540.54 |
| InChIKey | XNCHLCOISMLPJG-QFIPXVFZSA-N |
| SMILES | COC(=O)OCOc1c2n(ccc1=O)N(C1c3ccccc3SCc3c1ccc(F)c3F)CC1(CC1)C2=O |